Willeboordse Floor, Hugtenburg Jacqueline G, Schellevis François G, Elders Petra J M
Department of General Practice & Elderly Care Medicine, EMGO+ Institute for Health and Care Research, VU University Medical Center, Amsterdam, The Netherlands; NIVEL, (Netherlands Institute for Health Services Research), Utrecht, The Netherlands.
Br J Clin Pharmacol. 2014 Dec;78(6):1201-16. doi: 10.1111/bcp.12398.
The aim of this systematic literature review is to investigate which types of patient participation in medication reviews have been practiced and what is known about the effects of patient participation within the medication review process.
A systematic literature review was performed in multiple databases using an extensive selection and quality assessment procedure.
In total, 37 articles were included and most were assessed with a weak or moderate quality. In all studies patient participation in medication reviews was limited to the level of information giving by the patient to the professional, mainly on actual drug use. Nine studies showed limited results of effects of patient participation on the identification of drug related problems.
The effects of patient participation are not frequently studied and poorly described in current literature. Nevertheless, involving patients can improve patients' knowledge, satisfaction and the identification of drug related problems. Patient involvement is now limited to information sharing. The profit of higher levels of patient communication and shared decision making is until now, not supported by evidence of its effectiveness.
本系统文献综述的目的是调查在药物评估中实践了哪些类型的患者参与，以及关于患者参与药物评估过程的效果已知哪些情况。
使用广泛的筛选和质量评估程序在多个数据库中进行系统文献综述。
总共纳入37篇文章，大多数文章的质量评估为弱或中等。在所有研究中，患者参与药物评估仅限于患者向专业人员提供信息的层面，主要是关于实际用药情况。九项研究表明患者参与对识别药物相关问题的效果有限。
目前文献中对患者参与的效果研究不频繁且描述不佳。然而，让患者参与可以提高患者的知识水平、满意度以及识别药物相关问题的能力。目前患者参与仅限于信息共享。迄今为止，更高水平的患者沟通和共同决策的益处尚无其有效性的证据支持。
